Meliora Therapeutics

Meliora Therapeutics Puts Genomics and Cutting-Edge Computational Methods at the Forefront of Product Development, Reinventing Modern Oncology Drug Discovery. The company has developed "molecular fingerprints" for tens of thousands of compounds to build an inference engine that identifies risk-adjusted small molecule compounds and mechanisms of action (MOA).